Value-based contracting is a healthcare payment approach where providers earn reimbursement based on patient outcomes rather than the number of services they deliver. Instead of paying a set fee every time a doctor orders a test or performs a procedure, insurers and government programs tie payments to measurable results: Did the patient’s blood pressure improve? Were hospital readmissions avoided? Did the treatment actually work? The federal government is pushing hard in this direction, with a stated goal of placing 100 percent of traditional Medicare beneficiaries in accountable care relationships by 2030.
How It Differs From Fee-for-Service
The traditional fee-for-service model is straightforward. Services have specific costs, and after a provider delivers care, the insurer pays based on previously agreed-upon rates. The problem is that the only condition for payment is whether a service was provided, not whether it helped. There’s no built-in reason for providers to improve quality, coordinate with other clinicians, or focus on prevention. A doctor who orders five unnecessary imaging tests gets paid more than one who solves the problem in a single visit.
Value-based contracts flip that incentive. Providers are rewarded for keeping patients healthier, reducing complications, and avoiding unnecessary care. The model encourages information sharing between facilities and providers, creating more connected support networks. It also pushes preventive efforts in ways that fee-for-service struggles to accomplish, since keeping a patient out of the hospital is financially rewarded rather than financially punished.
Common Payment Structures
Value-based contracting isn’t a single model. It’s a spectrum of arrangements that shift increasing amounts of financial responsibility onto providers. The main structures include:
- Shared savings: Groups of doctors, hospitals, and other providers form an accountable care organization (ACO) and agree to be held collectively responsible for the quality, cost, and experience of care for a defined patient population. If the ACO delivers high-quality care at a lower cost than expected, it shares in the savings. In the lowest-risk version, providers keep a portion of savings (often 50 percent) but don’t owe anything if costs exceed the target.
- Bundled payments: A single negotiated price covers an entire episode of care, such as a hip replacement from pre-surgery through rehabilitation. If the provider delivers that care for less than the bundled amount while meeting quality standards, they keep the difference. If costs run over, they absorb the loss.
- Global capitation: The highest-risk arrangement. A provider or system receives a fixed payment per patient per month to cover all or most of that patient’s care. This is a full-risk model with 100 percent shared savings and shared losses.
Upside Risk vs. Downside Risk
One of the most important distinctions in value-based contracting is whether a provider faces only upside risk or both upside and downside risk. In a one-sided (upside-only) arrangement, providers who deliver quality care at a lower cost receive a bonus payment, but they don’t owe anything back if spending goes over the benchmark. It’s a low-stakes entry point that lets organizations learn value-based care without betting the farm.
Two-sided risk raises the stakes significantly. Providers who reduce spending while maintaining quality still earn bonuses, but those who increase overall spending owe a payment back to the payer. The financial exposure is real. In the Medicare Shared Savings Program’s 2024 performance year, 16 ACOs owed shared losses totaling $20 million. Most organizations start with upside-only contracts and gradually take on downside risk as they build the infrastructure and experience to manage it.
How Outcomes Are Measured
Value-based contracts live or die on measurement. Providers are evaluated against standardized quality metrics covering areas like cancer screening rates, blood pressure control, medication management for chronic conditions, hospital readmission rates, and follow-up care after mental health hospitalizations. The most widely used measurement set tracks performance across significant public health issues including heart disease, diabetes, behavioral health, and osteoporosis management.
Patient experience counts too. Plans use performance data to identify gaps, set improvement targets, and compare results across providers. These scores directly affect how much of the available savings a provider actually takes home. An ACO that cuts costs but lets quality slip won’t see the full financial reward.
Real-World Financial Results
The Medicare Shared Savings Program offers the clearest picture of how value-based contracting performs at scale. In 2024, 476 ACOs participated, covering 10.3 million beneficiaries. The results were the strongest in the program’s history: 75 percent of ACOs earned performance payments totaling $4.1 billion, and Medicare itself saved $2.5 billion relative to spending benchmarks. That means both providers and the government came out ahead financially while patients received coordinated, quality-measured care.
These numbers represent the best-case scenario, though. The remaining ACOs either broke even or lost money, and the program skews toward organizations large enough to invest in the data systems and care coordination teams that make value-based care work.
Value-Based Contracting for Pharmaceuticals
The concept extends beyond provider payments into drug pricing. In outcomes-based agreements between drug manufacturers and payers, the price of a medication is tied to whether it actually works for the patient. If a patient doesn’t respond to an expensive specialty drug, the manufacturer provides a rebate or adjusts the price.
These arrangements take several forms. Short-term models (under one year) include nonresponder rebates, where the manufacturer refunds some cost if the drug fails, and free trial periods that let patients start treatment before the payer commits. Longer-term models running up to five years use adjustable pricing that shifts based on real-world outcomes data. Success depends on having easily measurable health outcomes, trusted data sources, and unbiased third-party experts to verify results. Both payers and manufacturers generally prefer shorter agreements, though longer ones are workable with careful design.
What It Takes to Participate
The biggest barrier to value-based contracting isn’t willingness. It’s data infrastructure. Providers need the ability to track patient outcomes across settings, analyze population-level trends, identify high-risk patients before they end up in the emergency room, and report quality metrics back to payers. Large health systems can work with terabytes of raw data, but many smaller physician-led practices don’t have the resources to process and analyze that volume of information.
Attribution and benchmarking sit at the core of the challenge. Payers want to know which patients belong to which provider, what those patients’ outcomes look like, and how those results compare to spending targets. Getting this right requires interoperable data systems that can pull information from electronic health records, claims databases, and sometimes even social determinants of health. Some practices turn to third-party data aggregators that handle the analytics work, letting smaller organizations participate in value-based contracts without building an entire data team from scratch.
The transition is not optional for much of healthcare. With the federal government targeting universal accountable care by 2030, organizations that haven’t started building these capabilities face an increasingly narrow runway.